These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23285134)

  • 1. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling.
    Rowse AL; Naves R; Cashman KS; McGuire DJ; Mbana T; Raman C; De Sarno P
    PLoS One; 2012; 7(12):e52658. PubMed ID: 23285134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.
    Beurel E; Kaidanovich-Beilin O; Yeh WI; Song L; Palomo V; Michalek SM; Woodgett JR; Harrington LE; Eldar-Finkelman H; Martinez A; Jope RS
    J Immunol; 2013 May; 190(10):5000-11. PubMed ID: 23606540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
    Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A
    J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
    Mbanefo EC; Seifert A; Yadav MK; Yu CR; Nagarajan V; Parihar A; Singh S; Egwuagu CE
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
    Chong WP; Horai R; Mattapallil MJ; Silver PB; Chen J; Zhou R; Sergeev Y; Villasmil R; Chan CC; Caspi RR
    J Autoimmun; 2014 May; 50():12-22. PubMed ID: 24021664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet.
    Duhen R; Glatigny S; Arbelaez CA; Blair TC; Oukka M; Bettelli E
    J Immunol; 2013 May; 190(9):4478-82. PubMed ID: 23543757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
    Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
    PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
    You Z; Timilshina M; Jeong BS; Chang JH
    Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.
    Naves R; Singh SP; Cashman KS; Rowse AL; Axtell RC; Steinman L; Mountz JD; Steele C; De Sarno P; Raman C
    J Immunol; 2013 Sep; 191(6):2967-77. PubMed ID: 23960239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
    Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
    Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
    Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
    Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein translocation and retro-translocation across the endoplasmic reticulum are crucial to inflammatory effector CD4
    Pradeep Yeola A; Akbar I; Baillargeon J; Mercy Ignatius Arokia Doss P; Paavilainen VO; Rangachari M
    Cytokine; 2020 May; 129():154944. PubMed ID: 32146280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis.
    Muthian G; Raikwar HP; Rajasingh J; Bright JJ
    J Neurosci Res; 2006 May; 83(7):1299-309. PubMed ID: 16547967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
    Lee J; Choi J; Lee W; Ko K; Kim S
    Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter.
    Hill EV; Ng TH; Burton BR; Oakley CM; Malik K; Wraith DC
    Eur J Immunol; 2015 Apr; 45(4):1103-15. PubMed ID: 25627813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.